全文获取类型
收费全文 | 73767篇 |
免费 | 7105篇 |
国内免费 | 2990篇 |
专业分类
耳鼻咽喉 | 112篇 |
儿科学 | 3757篇 |
妇产科学 | 398篇 |
基础医学 | 5710篇 |
口腔科学 | 481篇 |
临床医学 | 9090篇 |
内科学 | 18351篇 |
皮肤病学 | 558篇 |
神经病学 | 1718篇 |
特种医学 | 2433篇 |
外国民族医学 | 7篇 |
外科学 | 23425篇 |
综合类 | 8779篇 |
现状与发展 | 15篇 |
一般理论 | 2篇 |
预防医学 | 1276篇 |
眼科学 | 1258篇 |
药学 | 3365篇 |
31篇 | |
中国医学 | 883篇 |
肿瘤学 | 2213篇 |
出版年
2024年 | 36篇 |
2023年 | 1175篇 |
2022年 | 1249篇 |
2021年 | 2599篇 |
2020年 | 2958篇 |
2019年 | 3135篇 |
2018年 | 3116篇 |
2017年 | 2654篇 |
2016年 | 2494篇 |
2015年 | 2622篇 |
2014年 | 4472篇 |
2013年 | 5133篇 |
2012年 | 3544篇 |
2011年 | 4286篇 |
2010年 | 3727篇 |
2009年 | 3837篇 |
2008年 | 3951篇 |
2007年 | 4136篇 |
2006年 | 4090篇 |
2005年 | 3627篇 |
2004年 | 2931篇 |
2003年 | 2498篇 |
2002年 | 2031篇 |
2001年 | 1774篇 |
2000年 | 1423篇 |
1999年 | 1224篇 |
1998年 | 1070篇 |
1997年 | 974篇 |
1996年 | 835篇 |
1995年 | 804篇 |
1994年 | 859篇 |
1993年 | 551篇 |
1992年 | 650篇 |
1991年 | 523篇 |
1990年 | 378篇 |
1989年 | 325篇 |
1988年 | 338篇 |
1987年 | 255篇 |
1986年 | 215篇 |
1985年 | 278篇 |
1984年 | 230篇 |
1983年 | 149篇 |
1982年 | 130篇 |
1981年 | 145篇 |
1980年 | 103篇 |
1979年 | 72篇 |
1978年 | 69篇 |
1977年 | 64篇 |
1976年 | 47篇 |
1975年 | 26篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
41.
Graft-versus-host disease (GVHD) is the most common complication after allogeneic hematopoietic stem cell transplantation, and also an important factor affecting the survival and quality of life in patients after transplantation. Currently, immunosuppressive therapy is commonly used for GVHD, but the curative effect is not ideal. How to effectively prevent and treat GVHD is one of the difficulties to be solved urgently in the field of transplantation. In this paper, we summarize the latest progress in pathogenesis, prevention and treatment of GVHD with Chinese medicine(CM). We hope it will provide ideas and methods for exploring the mechanism and establishing a new comprehensive therapy for GVHD with CM. 相似文献
42.
心脏外科专业型硕士研究生培养模式思考 《医学教育管理》2020,6(2):146-150,155
在我国临床医学专业学位硕士研究生同住院医师规范化培训并轨政策全面落实的背景下,心脏外科专业型硕士研究生从招生到培养过程中呈现出一些问题,通过从规范化培训计划的制定、人文素养和科研素养培育3个方面,结合教学体会提出了当前培养模式下对心脏外科专业型硕士研究生综合培养的思考。 相似文献
43.
目的:探讨超高CD34+采集的动员方案后序贯二次自体造血干细胞移植治疗难治性霍奇金淋巴瘤的疗效和安全性。方法:对1例经过多疗程一线、二线、新药、免疫等均难治的霍奇金淋巴瘤患者,予以IA+C方案化疗+G-CSF动员干细胞后采集出超高水平CD34+细胞,之后行自体造血干细胞移植,移植后获得完全缓解,再予序贯第二次自体造血干细胞移植进行巩固治疗。结果:总计输注单个核细胞数13.67×108/kg,CD34+细胞48.68×106/kg,第一次自体造血干细胞移植术后第7天造血功能恢复,复查全身PET-CT提示获得完全缓解,第二次自体造血干细胞移植术后第8天造血功能恢复,两次自体造血干细胞移植相关并发症均在可控范围内。结论:超高CD34+细胞采集的IA+C方案化疗+G-CSF动员可以让患者有机会进行多次自体造血干细胞移植,是临床动员的创新方案。对于难治性霍奇金淋巴瘤,序贯二次自体造血干细胞移植可达到更深层次缓解,且安全性较高,延长患者无疾病生存期及总生存期,为难治性霍奇金淋巴瘤治疗提供更多临床依据。 相似文献
44.
《Clinical Lymphoma, Myeloma & Leukemia》2020,20(8):e529-e541
IntroductionThe presence of FMS-like tyrosine kinase 3 (FLT3) internal tandem duplication (ITD) mutation in pediatric acute myeloid leukemia (AML) is associated with high rates of induction failure and worse survival. Its presence places the patient into a high-risk group. We aimed to describe the outcome of pediatric AML with FLT3-ITD mutation.Patients and MethodsWe performed a retrospective analysis of cases of AML from July 2007 till July 2017 at Children’s Cancer Hospital Egypt.ResultsSeventy-one patients had FLT3 gene mutation out of 687 patients with AML. Sixty-five patients had FLT3 gene mutation with allelic ratio > 0.4; 43 (66.1%) of 65 patients experienced complete remission (CR). Of the 43 patients, 16 patients maintained CR, 18 patients relapsed after first CR, 8 patients died, and 1 patient was lost to follow-up. Patients with relapsing disease died after salvage chemotherapy, except for one patient, who was alive after second CR. Allogeneic bone marrow transplantation (allo-BMT) was performed for 9 (13.8%) of 65 patients in first CR, of whom 8 were alive and in CR, and 1 patient experienced disease relapse and died. Seven patients (10.7%) were alive without allo-BMT. Three years’ overall and event-free survival for patients with FLT3-ITD mutation with high allelic ratio was 26.9% and 22.8%, respectively. Three years’ overall and event-free survival for patients treated with allo-BMT was 77.8% and 78.8%, respectively, versus patients treated without allo-BMT, 16.3% and 12.8%, respectively.ConclusionFLT3-ITD mutation in pediatric AML was associated with poor treatment outcomes, and the survival of relapsing patients was extremely poor. Allo-BMT in first remission was the best treatment option. Alternative donor transplants and FLT3 inhibitors are needed to improve outcome in developing countries. 相似文献
45.
Bo Cai Qiyun Sun Jianhui Qiao Changlin Yu Kaixun Hu Tieqiang Liu Bingxia Li Yajing Huang Yi Wang Hongli Zuo Zheng Dong Yaqing Lei Zhiqing Liu Bo Yao Caixia Li Huisheng Ai Mei Guo 《American journal of cancer research》2020,10(11):3852
Patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) have poor prognosis, and the efficacy of chemotherapy plus tyrosine kinase inhibitors (TKIs) followed by mismatched donor stem cell infusion (microtransplantation, MST) has not been determined. We retrospectively summarized 45 patients including 11 undergoing MST with TKIs, 17 receiving allogeneic transplant and 17 undergoing chemotherapy with TKIs. Improved 4-year overall survival rate was observed in the MST group (91%) compared with either transplant group (31%, P = .005) or chemotherapy group (36%, P = .013). The MST group also had higher 2-year and 4-year leukemia-free survival rates (91% and 72%, respectively) compared with either transplant group (33%, P = .005 and 33%, P = .021, respectively) or chemotherapy group (41%, P = .017 and 31%, P = .023, respectively). 2-year and 4-year cumulative incidences of hematologic relapse were lower in the MST group (9% and 28%, respectively) compared with those in the chemotherapy group (56%, P = .025 and 67%, P = .034, respectively). In patients undergoing MST, donor microchimerism was detected (1.07 × 10-5 to 6.6 × 10-4 copies from 9 to 1499 days) in 7 patients, and donor/patient-derived HLA*0201/2402+WT1+CD8+ T cells were found from 0.05% to 0.67% in 6 patients. MST may provide a favorable treatment for patients with Ph+ ALL. 相似文献
46.
47.
目的回顾性分析聊城市人民医院近7年来,围术期24 h内发生心搏骤停患者的医学资料,为预防这一严重不良事件提供有益信息。方法通过我院手术麻醉电子系统,调阅不良事件上报系统,选取2013-07/2020-12期间在我院手术室接受非心脏手术围术期发生心搏骤停患者的医疗记录进行分析、归纳总结。结果共116152名患者接受非心脏手术麻醉,围术期发生心搏骤停33例(2.8/10000),21例复苏失败,死亡率1.8/10000。麻醉完全相关2例,麻醉部分相关12例,麻醉相关心搏骤停发生率1.2/10000。与麻醉不相关心搏骤停患者基本资料比较,差异无统计学意义。结论围术期心搏骤停原因复杂多样,失血性休克以及感染性休克,是围术期心搏骤停最常见的原因,麻醉医生应熟知各种不同类型心搏骤停病理生理机制,以便实施快速有效的抢救措施。 相似文献
48.
49.
Joakim Nordanstig Odd Bech-Hanssen Per Skoog Lennart Jivegård 《Scandinavian cardiovascular journal : SCJ》2019,53(3):153-161
Objective. Skeletal muscle perfusion during walking relies on complex interactions between cardiac activity and vascular control mechanisms, why cardiac dysfunction may contribute to intermittent claudication (IC) symptoms. The study aims were to describe cardiac function at rest and during stress in consecutive IC patients, to explore the relations between cardiac function parameters and treadmill performance, and to test the hypothesis that clinically silent myocardial ischemia during stress may contribute to IC limb symptomatology. Design. Patients with mild to severe IC (n?=?111, mean age 67 y, 52% females, mean treadmill distance 195 m) underwent standard echocardiography, dobutamine stress echocardiography (SE) and treadmill testing. The patient cohort was separated in two groups based on treadmill performance (HIGH and LOW performance). Results. Ten patients (9%) had regional wall motion abnormalities of which three had left ventricular ejection fraction <50% at standard echocardiography. A majority had lower than expected systolic- and diastolic ventricular volumes. LOW performers had smaller diastolic left ventricular volumes and lower global peak systolic velocity during dobutamine stress. No patient demonstrated significant cardiac dysfunction during dobutamine provocation that was not also evident at standard echocardiography. Conclusions. Most IC patients were without signs of ischemic heart disease or cardiac failure. The majority had small left ventricular volumes. The hypothesis that clinically silent myocardial ischemia impairing left ventricular function during stress may contribute to IC limb symptomatology was not supported.Trial registration: ClinicalTrials.gov identifier: NCT01219842. 相似文献
50.
Karen K. Stout Curt J. Daniels Jamil A. Aboulhosn Biykem Bozkurt Craig S. Broberg Jack M. Colman Stephen R. Crumb Joseph A. Dearani Stephanie Fuller Michelle Gurvitz Paul Khairy Michael J. Landzberg Arwa Saidi Anne Marie Valente George F. Van Hare 《Journal of the American College of Cardiology》2019,73(12):e81-e192